Signaling pathways
-
BA8801 DPHSummary: DPH is a potent, cell-permeable activator. -
BA8803 FlumatinibSummary: Flumatinib is a selective inhibitor with oral activity. - BA8804 VodobatinibSummary: Vodobatinib (K0706) is a potent third-generation, and orally active, tyrosine kinase inhibitor.
- BA8805 SIAIS178Summary: SIAIS178 is a class of effective, selective degradation agents.
- BA8807 BCR-ABL-IN-8Summary: An inhibitor containing trimethoxy (trimethoxygroup).
- BA8809 AKE-72Summary: AKE-72 is a potent inhibitor.
- BA8810 HG-7-86-01Summary: HG-7-86-01 is a type II tyrosine kinase inhibitor.
- BA8811 CHMFL-BMX-078Summary: CHMFL-BMX-078 is a potent, selective, irreversible, type II kinase inhibitor.
- BA8812 TilfrinibSummary: Tilfrinib is a potent and selective inhibitor.
- BA8813 SB-633825Summary: SB-633825 is a potent, ATP-competitive inhibitor.